A researcher from FAU and collaborators compared patients with tinnitus before and during the COVID-19 pandemic to assess if the severity of tinnitus was influenced by the lockdown related to the pandemic.
According to Schmidt College of Medicine researchers, most emergency departments in the U.S. and worldwide do not provide the level of service recommended by the Geriatric Emergency Department Guidelines.
FAU has selected four Ph.D. students whose work embraces computational neuroscience to receive the inaugural Palm Health Foundation Computational Brain Health Graduate Fellowships.
Ivermectin is not approved by the FDA to treat or prevent COVID-19. Nonetheless, prescriptions of ivermectin by U.S. health care providers increased more than tenfold from 3,589 per week pre-COVID-19 to 39,102.
Lisa Ann Brennan, Ph.D., an associate research professor in the Schmidt College of Medicine, will receive the prestigious 2022 National Foundation for Eye Research's "Cataract Research Award" in May.
FAU engineering and biomedical science researchers are developing an affordable and reliable, automated HIV self-test that will increase access and improve treatment outcomes in any setting.
Researchers provide a perspective on aspirin to prevent heart attacks and stroke and urge health care providers to make clinical judgements on a case-by-case basis and based on benefit-to-risk and not age.
Early distribution of COVID-19 vaccines in Florida reached the intended senior population, but it failed to ensure equal access for lower-income and minority communities, according to a new study.
A world-renowned clinician-researcher has joined the Schmidt College of Medicine to direct the FAU Center for Brain Health to focus on Alzheimer's disease and neurodegenerative dementia prevention.
Julie G. Pilitsis, M.D., Ph.D., a leading neurosurgeon and physician scientist, will assume this role in February 2022.